logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Healthcare Roundup – Healthcare Companies EPS beats: CorMedix, Glaukos

Nov 6, 2020

Life Science

Healthcare Roundup – Healthcare rallies as Presidential vote count continues, Novavax inks pact with Australia

Nov 4, 2020

Life Science

Healthcare Roundup – Canopy Growth switches listing to Nasdaq, Brazil on board with resumption of J&J COVID-19 vaccine study

Nov 3, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Closing of Debt Settlement

Oct 28, 2020

Life Science

Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx

Oct 27, 2020

Life Science

Lineage Cell Therapeutics

Developing New Treatments with a Proprietary Cell-Based Therapy Platform | Lineage Cell Therapeutics, Inc. (NYSE American: LCTX)

Oct 27, 2020

Life Science

Healthcare Roundup – Lilly ends COVID-19 antibody trial, Moderna inks COVID-19 vaccine supply deal in Qatar

Oct 27, 2020

Life Science

医疗保健精选——FDA对COVID-19疫苗紧急使用授权缺乏热情,阿斯利康新冠疫苗协议的毛利润高达20%

Healthcare Roundup – FDA getting cold feet on EUA nod for COVID-19 vaccines, AstraZeneca COVID-19 deal allows 20% gross profit

Oct 23, 2020

Life Science

医疗保健精选——FDA批准吉利德瑞德西韦,Moderna完成新冠疫苗患者的三期研究入组

Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine

Oct 23, 2020

Life Science

医疗保健精选——强生daratumumab延长一线多发性骨髓瘤的生存期,阿斯利康新冠疫苗志愿者死亡

Healthcare Roundup – J&J’s daratumumab extends survival in first-line multiple myeloma, Death reported in Brazil study of AstraZeneca COVID-19 vaccine

Oct 22, 2020

Life Science

医疗保健精选——CytoDyn的leronlimab治疗新冠患者的实验取得成功,Novavax将展示COVID-19疫苗数据

Healthcare Roundup – CytoDyn study of leronlimab for COVID-19 passes first interim tollgate, Novavax to present COVID-19 vaccine data

Oct 21, 2020

Life Science

医疗保健精选——CVS希望再招募15,000名员工,辉瑞和Moderna新冠疫苗的关键研究接近入组目标

Healthcare Roundup – CVS looks to hire another 15,000 employees, Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets

Oct 20, 2020

Life Science

中国科兴获投资,加速COVID-19疫苗开发

Healthcare Roundup – Sinovac’s COVID-19 vaccine offered by Chinese city for emergency use, CytoDyn to discuss DSMC’s review of interim analysis in COVID-19

Oct 17, 2020

Life Science

医疗保健精选——瑞德昔韦对新冠病毒死亡率几乎没有影响,世界卫生组织将吉利德的瑞德昔韦加入资格预审清单

Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir

Oct 16, 2020

Life Science

Healthcare Roundup – Trump administration expands collaboration with AstraZeneca on COVID-19 antibody drug, Moderna makes headway in bringing COVID vaccine to European market

Oct 14, 2020

Life Science

医疗保健精选——美国确认首例新冠二次感染病例,Relief/NeuroRx报告令人鼓舞的Aviptadil数据

Healthcare Roundup – First case of COVID-19 reinfection confirmed in the U.S.; Relief/NeuroRx reports encouraging Aviptadil data

Oct 13, 2020

Life Science

医疗保健综述-礼来/信达生物利妥昔单抗注射液在中国获得许可;辉瑞和BioNTech提交COVID-19候选疫苗滚动审查申请

Healthcare Roundup – Lilly/Innovent rituximab injection OK’d in China; BioNTech, Pfizer announce rolling submission for COVID-19 vaccine candidate

Oct 9, 2020

Life Science

Healthcare Roundup – Late-stage study of Emergent Bio’s COVID-19 plasma, Lilly’s baricitinib shows incremental benefit

Oct 9, 2020

Life Science

  • ‹‹ Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada